News Release

Eurasia trading places trial order

Date: 2000/03/22

International Wex Technologies Inc. (the "company") is pleased that the 5-year contract announced May 17, 1999 with Eurasia Health Trading bv has commenced. Eurasia, of the Netherlands, has instructed that the first shipment of premium green tea, sourced by us in China, be shipped via the port of Antwerp, Belgium as a trial order.

The company believes that by using this initial shipment as a test run, Eurasia will ultimately prove to be a major revenue source for International Wex Technologies Inc.

International Wex Technologies Inc. will be sourcing and supplying a wide range of products of Chinese origin for Eurasia. Eurasia is obligated to secure all import and permits for the EEUC and Switzerland.

Tetrodin(HT) has been developed by the company primarily as a treatment for the symptoms associated with withdrawal from all opiate addictions such as morphine, opium, heroin and methadone. It is a non-narcotic pharmaceutical that has proven to be safe and effective and functions well in both primary withdrawal treatment and abstinence maintenance (longer term use) of drug addiction. The company has also begun tests on the usage of Tetrodin(HT) as a potent analgesic.

For additional information on Tetrodin(HT), view the IWT website at http://www.wextech.ca or call Howard Milne , V. P. Shareholder Communications, at 604-683-8880 or 1-800-722-7549.

Per: Donna Shum, Corporate Secretary